APO Research
Talk to an analyst

APO RESEARCH · REPORT

Personalized Precision Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Personalized Precision Medicine Market Analysis and Forecast 2026-2032

3 March 2026207 pages

Choose your research edition.

Industry ResearchPersonalized Precision Medicine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Precision Medicine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Personalized Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Precision Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Precision Medicine Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Personalized Precision Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Personalized Precision Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Personalized Precision Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Personalized Precision Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Personalized Precision Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Personalized Precision Medicine include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Personalized Precision Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Personalized Precision Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Personalized Precision Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Personalized Precision Medicine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Personalized Precision Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Personalized Precision Medicine revenue, projected growth trends, production technology, application and end-user industry.

Personalized Precision Medicine Segment by Company

Agilent Technologies

Biogen

Johnson & Johnson

Boai NKY Pharmaceuticals Ltd.

Novartis

Pfizer

Roche

AstraZeneca

Sanofi

Amgen

Takeda Pharmaceutical

Merck

Eli Lilly

IQVIA

AbbVie

Parexel

Personalized Precision Medicine Segment by Type

Gene Therapy

Personalized Medication

Health Management

Others

Personalized Precision Medicine Segment by Application

Tumors and Cancer

Cardiovascular Diseases

Genetic Disease

Autoimmune Disease

Others

Personalized Precision Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Personalized Precision Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Personalized Precision Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Precision Medicine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Personalized Precision Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Therapy Major Player Table 3. Personalized Medication Major Player Table 4. Health Management Major Player Table 5. Others Major Player Table 6. Global Personalized Precision Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Tumors and Cancer Major Player Table 8. Cardiovascular Diseases Major Player Table 9. Genetic Disease Major Player Table 10. Autoimmune Disease Major Player Table 11. Others Major Player Table 12. Personalized Precision Medicine Industry Trends Table 13. Personalized Precision Medicine Industry Drivers Table 14. Personalized Precision Medicine Industry Opportunities and Challenges Table 15. Personalized Precision Medicine Industry Restraints Table 16. Global Personalized Precision Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Personalized Precision Medicine Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Personalized Precision Medicine Market Share by Region (2021-2026) Table 19. Global Personalized Precision Medicine Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Personalized Precision Medicine Market Share by Region (2027-2032) Table 21. Global Personalized Precision Medicine Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Personalized Precision Medicine Revenue Market Share by Players (2021-2026) Table 23. Global Personalized Precision Medicine Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Personalized Precision Medicine Key Players Headquarters & Area Served Table 25. Global Personalized Precision Medicine Players, Product Type & Application Table 26. Global Personalized Precision Medicine Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Personalized Precision Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Personalized Precision Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Personalized Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Personalized Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Personalized Precision Medicine Revenue Market Share by Type (2021-2026) Table 33. Global Personalized Precision Medicine Revenue Market Share by Type (2027-2032) Table 34. Global Personalized Precision Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Personalized Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Personalized Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Personalized Precision Medicine Revenue Market Share by Application (2021-2026) Table 38. Global Personalized Precision Medicine Revenue Market Share by Application (2027-2032) Table 39. Agilent Technologies Company Information Table 40. Agilent Technologies Business Overview Table 41. Agilent Technologies Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Agilent Technologies Personalized Precision Medicine Product Portfolio Table 43. Agilent Technologies Recent Development Table 44. Biogen Company Information Table 45. Biogen Business Overview Table 46. Biogen Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Biogen Personalized Precision Medicine Product Portfolio Table 48. Biogen Recent Development Table 49. Johnson & Johnson Company Information Table 50. Johnson & Johnson Business Overview Table 51. Johnson & Johnson Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Johnson & Johnson Personalized Precision Medicine Product Portfolio Table 53. Johnson & Johnson Recent Development Table 54. Boai NKY Pharmaceuticals Ltd. Company Information Table 55. Boai NKY Pharmaceuticals Ltd. Business Overview Table 56. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio Table 58. Boai NKY Pharmaceuticals Ltd. Recent Development Table 59. Novartis Company Information Table 60. Novartis Business Overview Table 61. Novartis Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Novartis Personalized Precision Medicine Product Portfolio Table 63. Novartis Recent Development Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Pfizer Personalized Precision Medicine Product Portfolio Table 68. Pfizer Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Roche Personalized Precision Medicine Product Portfolio Table 73. Roche Recent Development Table 74. AstraZeneca Company Information Table 75. AstraZeneca Business Overview Table 76. AstraZeneca Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. AstraZeneca Personalized Precision Medicine Product Portfolio Table 78. AstraZeneca Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Sanofi Personalized Precision Medicine Product Portfolio Table 83. Sanofi Recent Development Table 84. Amgen Company Information Table 85. Amgen Business Overview Table 86. Amgen Personalized Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Amgen Personalized Precision Medicine Product Portfolio Table 88. Amgen Recent Development Table 89. Takeda Pharmaceutical Company Information Table 90. Takeda Pharmaceutical Business Overview Table 91. Takeda Pharmaceutical Personalized Precision Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio Table 93. Takeda Pharmaceutical Recent Development Table 94. Merck Company Information Table 95. Merck Business Overview Table 96. Merck Personalized Precision Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Merck Personalized Precision Medicine Product Portfolio Table 98. Merck Recent Development Table 99. Eli Lilly Company Information Table 100. Eli Lilly Business Overview Table 101. Eli Lilly Personalized Precision Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Eli Lilly Personalized Precision Medicine Product Portfolio Table 103. Eli Lilly Recent Development Table 104. IQVIA Company Information Table 105. IQVIA Business Overview Table 106. IQVIA Personalized Precision Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. IQVIA Personalized Precision Medicine Product Portfolio Table 108. IQVIA Recent Development Table 109. AbbVie Company Information Table 110. AbbVie Business Overview Table 111. AbbVie Personalized Precision Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. AbbVie Personalized Precision Medicine Product Portfolio Table 113. AbbVie Recent Development Table 114. Parexel Company Information Table 115. Parexel Business Overview Table 116. Parexel Personalized Precision Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Parexel Personalized Precision Medicine Product Portfolio Table 118. Parexel Recent Development Table 119. North America Personalized Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Personalized Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Personalized Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Personalized Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Personalized Precision Medicine Revenue by Country (2021-2026) & (US$ Million) Table 125. North America Personalized Precision Medicine Revenue by Country (US$ Million) & (2027-2032) Table 126. Europe Personalized Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Personalized Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Personalized Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Personalized Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Personalized Precision Medicine Revenue by Country (2021-2026) & (US$ Million) Table 132. Europe Personalized Precision Medicine Revenue by Country (US$ Million) & (2027-2032) Table 133. China Personalized Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 134. China Personalized Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 135. China Personalized Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 136. China Personalized Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Personalized Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Personalized Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Personalized Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Personalized Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Personalized Precision Medicine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Personalized Precision Medicine Revenue by Region (US$ Million) & (2021-2026) Table 143. Asia Personalized Precision Medicine Revenue by Region (US$ Million) & (2027-2032) Table 144. SAMEA Personalized Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 145. SAMEA Personalized Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 146. SAMEA Personalized Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 147. SAMEA Personalized Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 148. SAMEA Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. SAMEA Personalized Precision Medicine Revenue by Country (2021-2026) & (US$ Million) Table 150. SAMEA Personalized Precision Medicine Revenue by Country (US$ Million) & (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Personalized Precision Medicine Image Figure 2. Global Personalized Precision Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Personalized Precision Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Personalized Medication Image Figure 6. Health Management Image Figure 7. Others Image Figure 8. Global Personalized Precision Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Personalized Precision Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Tumors and Cancer Image Figure 11. Cardiovascular Diseases Image Figure 12. Genetic Disease Image Figure 13. Autoimmune Disease Image Figure 14. Others Image Figure 15. Global Personalized Precision Medicine Market Size (US$ Million) & (2021-2032) Figure 16. Global Personalized Precision Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Personalized Precision Medicine Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Personalized Precision Medicine Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Personalized Precision Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Personalized Precision Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Personalized Precision Medicine Revenue Market Share by Type (2021-2032) Figure 23. Global Personalized Precision Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Personalized Precision Medicine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Personalized Precision Medicine Revenue Market Share by Application (2021-2032) Figure 26. North America Personalized Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Personalized Precision Medicine Revenue Share by Type (2021-2032) Figure 28. North America Personalized Precision Medicine Revenue Share by Application (2021-2032) Figure 29. North America Personalized Precision Medicine Revenue Share by Country (2021-2032) Figure 30. United States Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Personalized Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Personalized Precision Medicine Revenue Share by Type (2021-2032) Figure 35. Europe Personalized Precision Medicine Revenue Share by Application (2021-2032) Figure 36. Europe Personalized Precision Medicine Revenue Share by Country (2021-2032) Figure 37. Germany Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Personalized Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Personalized Precision Medicine Revenue Share by Type (2021-2032) Figure 47. China Personalized Precision Medicine Revenue Share by Application (2021-2032) Figure 48. Asia Personalized Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Personalized Precision Medicine Revenue Share by Type (2021-2032) Figure 50. Asia Personalized Precision Medicine Revenue Share by Application (2021-2032) Figure 51. Asia Personalized Precision Medicine Revenue Share by Region (2021-2032) Figure 52. Japan Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Personalized Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Personalized Precision Medicine Revenue Share by Type (2021-2032) Figure 60. SAMEA Personalized Precision Medicine Revenue Share by Application (2021-2032) Figure 61. SAMEA Personalized Precision Medicine Revenue Share by Country (2021-2032) Figure 62. Brazil Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Personalized Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Personalized Medication
  • Health Management
  • Others
Applications
  • Tumors and Cancer
  • Cardiovascular Diseases
  • Genetic Disease
  • Autoimmune Disease
  • Others
Companies covered
  • Agilent Technologies
  • Biogen
  • Johnson & Johnson
  • Boai NKY Pharmaceuticals Ltd.
  • Novartis
  • Pfizer
  • Roche
  • AstraZeneca
  • Sanofi
  • Amgen
  • Takeda Pharmaceutical
  • Merck
  • Eli Lilly
  • IQVIA
  • AbbVie
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Personalized Precision Medicine Market by Type
  3. 1.2.1 Global Personalized Precision Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Personalized Medication
  6. 1.2.4 Health Management
  7. 1.2.5 Others
  8. 1.3 Personalized Precision Medicine Market by Application
  9. 1.3.1 Global Personalized Precision Medicine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Tumors and Cancer
  11. 1.3.3 Cardiovascular Diseases
  12. 1.3.4 Genetic Disease
  13. 1.3.5 Autoimmune Disease
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Personalized Precision Medicine Market Dynamics
  1. 2.1 Personalized Precision Medicine Industry Trends
  2. 2.2 Personalized Precision Medicine Industry Drivers
  3. 2.3 Personalized Precision Medicine Industry Opportunities and Challenges
  4. 2.4 Personalized Precision Medicine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Personalized Precision Medicine Market Perspective (2021-2032)
  2. 3.2 Global Personalized Precision Medicine Growth Trends by Region
  3. 3.2.1 Global Personalized Precision Medicine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Personalized Precision Medicine Market Size by Region (2021-2026)
  5. 3.2.3 Global Personalized Precision Medicine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Personalized Precision Medicine Revenue by Players
  2. 4.1.1 Global Personalized Precision Medicine Revenue by Players (2021-2026)
  3. 4.1.2 Global Personalized Precision Medicine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Personalized Precision Medicine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Personalized Precision Medicine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Personalized Precision Medicine Key Players Headquarters & Area Served
  7. 4.4 Global Personalized Precision Medicine Players, Product Type & Application
  8. 4.5 Global Personalized Precision Medicine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Personalized Precision Medicine Market CR5 and HHI
  11. 4.6.3 2025 Personalized Precision Medicine Tier 1, Tier 2, and Tier 3
5 Personalized Precision Medicine Market Size by Type
  1. 5.1 Global Personalized Precision Medicine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Personalized Precision Medicine Revenue by Type (2021-2032)
  3. 5.3 Global Personalized Precision Medicine Revenue Market Share by Type (2021-2032)
6 Personalized Precision Medicine Market Size by Application
  1. 6.1 Global Personalized Precision Medicine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Personalized Precision Medicine Revenue by Application (2021-2032)
  3. 6.3 Global Personalized Precision Medicine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Agilent Technologies
  2. 7.1.1 Agilent Technologies Company Information
  3. 7.1.2 Agilent Technologies Business Overview
  4. 7.1.3 Agilent Technologies Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Agilent Technologies Personalized Precision Medicine Product Portfolio
  6. 7.1.5 Agilent Technologies Recent Developments
  7. 7.2 Biogen
  8. 7.2.1 Biogen Company Information
  9. 7.2.2 Biogen Business Overview
  10. 7.2.3 Biogen Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biogen Personalized Precision Medicine Product Portfolio
  12. 7.2.5 Biogen Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Personalized Precision Medicine Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Boai NKY Pharmaceuticals Ltd.
  20. 7.4.1 Boai NKY Pharmaceuticals Ltd. Company Information
  21. 7.4.2 Boai NKY Pharmaceuticals Ltd. Business Overview
  22. 7.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio
  24. 7.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Personalized Precision Medicine Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Personalized Precision Medicine Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche Personalized Precision Medicine Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 AstraZeneca
  44. 7.8.1 AstraZeneca Company Information
  45. 7.8.2 AstraZeneca Business Overview
  46. 7.8.3 AstraZeneca Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AstraZeneca Personalized Precision Medicine Product Portfolio
  48. 7.8.5 AstraZeneca Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Personalized Precision Medicine Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Amgen
  56. 7.10.1 Amgen Company Information
  57. 7.10.2 Amgen Business Overview
  58. 7.10.3 Amgen Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Amgen Personalized Precision Medicine Product Portfolio
  60. 7.10.5 Amgen Recent Developments
  61. 7.11 Takeda Pharmaceutical
  62. 7.11.1 Takeda Pharmaceutical Company Information
  63. 7.11.2 Takeda Pharmaceutical Business Overview
  64. 7.11.3 Takeda Pharmaceutical Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio
  66. 7.11.5 Takeda Pharmaceutical Recent Developments
  67. 7.12 Merck
  68. 7.12.1 Merck Company Information
  69. 7.12.2 Merck Business Overview
  70. 7.12.3 Merck Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Merck Personalized Precision Medicine Product Portfolio
  72. 7.12.5 Merck Recent Developments
  73. 7.13 Eli Lilly
  74. 7.13.1 Eli Lilly Company Information
  75. 7.13.2 Eli Lilly Business Overview
  76. 7.13.3 Eli Lilly Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Eli Lilly Personalized Precision Medicine Product Portfolio
  78. 7.13.5 Eli Lilly Recent Developments
  79. 7.14 IQVIA
  80. 7.14.1 IQVIA Company Information
  81. 7.14.2 IQVIA Business Overview
  82. 7.14.3 IQVIA Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  83. 7.14.4 IQVIA Personalized Precision Medicine Product Portfolio
  84. 7.14.5 IQVIA Recent Developments
  85. 7.15 AbbVie
  86. 7.15.1 AbbVie Company Information
  87. 7.15.2 AbbVie Business Overview
  88. 7.15.3 AbbVie Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  89. 7.15.4 AbbVie Personalized Precision Medicine Product Portfolio
  90. 7.15.5 AbbVie Recent Developments
  91. 7.16 Parexel
  92. 7.16.1 Parexel Company Information
  93. 7.16.2 Parexel Business Overview
  94. 7.16.3 Parexel Personalized Precision Medicine Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Parexel Personalized Precision Medicine Product Portfolio
  96. 7.16.5 Parexel Recent Developments
8 North America
  1. 8.1 North America Personalized Precision Medicine Revenue (2021-2032)
  2. 8.2 North America Personalized Precision Medicine Revenue by Type (2021-2032)
  3. 8.2.1 North America Personalized Precision Medicine Revenue by Type (2021-2026)
  4. 8.2.2 North America Personalized Precision Medicine Revenue by Type (2027-2032)
  5. 8.3 North America Personalized Precision Medicine Revenue Share by Type (2021-2032)
  6. 8.4 North America Personalized Precision Medicine Revenue by Application (2021-2032)
  7. 8.4.1 North America Personalized Precision Medicine Revenue by Application (2021-2026)
  8. 8.4.2 North America Personalized Precision Medicine Revenue by Application (2027-2032)
  9. 8.5 North America Personalized Precision Medicine Revenue Share by Application (2021-2032)
  10. 8.6 North America Personalized Precision Medicine Revenue by Country
  11. 8.6.1 North America Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Personalized Precision Medicine Revenue by Country (2021-2026)
  13. 8.6.3 North America Personalized Precision Medicine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Personalized Precision Medicine Revenue (2021-2032)
  2. 9.2 Europe Personalized Precision Medicine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Personalized Precision Medicine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Personalized Precision Medicine Revenue by Type (2027-2032)
  5. 9.3 Europe Personalized Precision Medicine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Personalized Precision Medicine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Personalized Precision Medicine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Personalized Precision Medicine Revenue by Application (2027-2032)
  9. 9.5 Europe Personalized Precision Medicine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Personalized Precision Medicine Revenue by Country
  11. 9.6.1 Europe Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Personalized Precision Medicine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Personalized Precision Medicine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Personalized Precision Medicine Revenue (2021-2032)
  2. 10.2 China Personalized Precision Medicine Revenue by Type (2021-2032)
  3. 10.2.1 China Personalized Precision Medicine Revenue by Type (2021-2026)
  4. 10.2.2 China Personalized Precision Medicine Revenue by Type (2027-2032)
  5. 10.3 China Personalized Precision Medicine Revenue Share by Type (2021-2032)
  6. 10.4 China Personalized Precision Medicine Revenue by Application (2021-2032)
  7. 10.4.1 China Personalized Precision Medicine Revenue by Application (2021-2026)
  8. 10.4.2 China Personalized Precision Medicine Revenue by Application (2027-2032)
  9. 10.5 China Personalized Precision Medicine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Personalized Precision Medicine Revenue (2021-2032)
  2. 11.2 Asia Personalized Precision Medicine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Personalized Precision Medicine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Personalized Precision Medicine Revenue by Type (2027-2032)
  5. 11.3 Asia Personalized Precision Medicine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Personalized Precision Medicine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Personalized Precision Medicine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Personalized Precision Medicine Revenue by Application (2027-2032)
  9. 11.5 Asia Personalized Precision Medicine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Personalized Precision Medicine Revenue by Country
  11. 11.6.1 Asia Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Personalized Precision Medicine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Personalized Precision Medicine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Personalized Precision Medicine Revenue (2021-2032)
  2. 12.2 SAMEA Personalized Precision Medicine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Personalized Precision Medicine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Personalized Precision Medicine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Personalized Precision Medicine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Personalized Precision Medicine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Personalized Precision Medicine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Personalized Precision Medicine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Personalized Precision Medicine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Personalized Precision Medicine Revenue by Country
  11. 12.6.1 SAMEA Personalized Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Personalized Precision Medicine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Personalized Precision Medicine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst